UK Independent. Sourced. Primary. · Est. 2024
Home Compare Travel Insurance Best Travel Insurance for COPD UK 2026
Compare Travel Insurance

Best Travel Insurance for COPD UK 2026

COPD is a declarable pre-existing condition, and FCDO guidance warns that failing to declare may invalidate cover. How medical screening, stability and specialist UK insurers work.

CT
Chandraketu Tripathi
Finance Editor, Kaeltripton
Published 5 Jun 2026
Last reviewed 5 Jun 2026
✓ Fact-checked
Best Travel Insurance for COPD UK 2026
Advertisement
TRAVEL INSURANCE · BUYER GUIDE
KEY FACTS
  • Chronic obstructive pulmonary disease (COPD) is a declarable pre-existing condition. FCDO guidance states that failing to declare something may invalidate your travel insurance.
  • Specialist medical screening for COPD typically asks about prescribed medicines, hospital admissions in the past year, breathlessness on flat ground, home oxygen use and recent chest infections.
  • Staysure (a trading name of TICORP Limited, FCA FRN 663617) covers more than 1,300 medical conditions with no upper age limit and unlimited emergency medical cover on Comprehensive and Signature policies.
  • ABI members paid 472 million pounds across more than 500,000 travel claims in 2024, with the average medical claim at 1,528 pounds and one USA case exceeding 1 million pounds.
Important

A standard policy bought without declaring COPD may pay nothing toward a respiratory flare-up abroad. The FCDO advises declaring existing conditions or pending treatment or tests so that you are covered if there are related complications.

How COPD cover differs from standard travel insurance

Chronic obstructive pulmonary disease is a long-term lung condition that covers diagnoses including chronic bronchitis and emphysema. For travel insurance purposes it sits in the category of pre-existing medical conditions, which means it must be declared before a policy will respond to a related claim. The Foreign, Commonwealth and Development Office is explicit on this point: travellers should declare existing conditions or pending treatment or tests, and failing to declare something may invalidate your travel insurance.

A standard off-the-shelf policy is priced on the assumption that the traveller has no significant ongoing illness. COPD changes the risk profile because a chest infection, exacerbation or oxygen requirement abroad can lead to emergency hospital treatment and, in serious cases, repatriation. The ABI reported that its members paid 472 million pounds across more than 500,000 travel claims in 2024, with medical claims accounting for 262 million pounds and 34 percent of all claims, up from 29 percent in 2023. The average medical claim was 1,528 pounds, and one member paid over 1 million pounds for hospital treatment in the USA followed by repatriation. Those figures explain why insurers screen lung conditions carefully rather than declining to ask.

What COPD screening actually asks

Buying cover for COPD usually means completing a medical screening at the quote stage. Rather than a single tick-box, the screening explores how stable and severe the condition is. On AllClear, a specialist provider that lists COPD under its respiratory conditions, the screening questions include how many medicines are prescribed for the condition, how many hospital admissions there have been in the past year, how short of breath the traveller gets when walking on flat ground, whether a prescription for oxygen has been received other than when in hospital, whether the person has ever been a smoker, and whether there has been a chest infection or an episode of pneumonia in the last year.

Those questions matter because the answers determine both whether cover is offered and what it costs. A recent hospital admission, an escalation in medication, or a new oxygen prescription tends to raise the premium or trigger additional terms. Answering accurately is not optional housekeeping: the screening forms part of the declaration, and an inaccurate answer can leave a respiratory claim unpaid. It is also worth screening any other recurring illnesses, ongoing or lifelong conditions and previous surgeries at the same time, because a related complication abroad may involve more than the lung condition alone.

Stability periods and pending tests

Insurers frequently frame eligibility around stability. In practice this means the condition has not worsened, the medication has not changed and there has been no new investigation within a defined recent window before either buying the policy or travelling. COPD can be progressive, so a traveller whose treatment was altered in the weeks before a trip may be asked to re-screen or re-declare. Pending tests deserve particular attention. The FCDO guidance covers not only existing conditions but pending treatment or tests, so a chest scan or specialist referral that has not yet produced a result should still be disclosed. Waiting for results is not the same as having no condition to declare.

Cover limits and exclusions to check

For a respiratory condition the emergency medical and repatriation limit is the figure that carries the most weight, because a serious exacerbation abroad is the scenario the policy exists to fund. The FCDO advises that cover should run for the full length of the trip, should pay for treatment in state or private hospitals, and should fund emergency transport such as an ambulance, which is often charged separately. On AllClear, the respiratory tiers illustrate the spread: the Gold tier offers emergency medical up to 10 million pounds with cancellation up to 2,000 pounds; Gold Plus offers up to 15 million pounds medical and up to 15,000 pounds cancellation; and Platinum offers unlimited emergency medical with cancellation up to 25,000 pounds. AllClear states that its respiratory cover can extend to hospital treatment abroad for flare-ups or infections, oxygen therapy or nebuliser use while travelling, lost or stolen inhalers and medication, and repatriation if the condition worsens.

Exclusions to read closely include any cap that applies specifically to the declared condition, the treatment of complications arising from undeclared conditions, and the handling of cancellation if the traveller becomes too unwell to fly. The FCDO also notes that some insurers may waive any excess on medical treatment if you use a GHIC, though this is not automatic and the policy terms should be checked. A GHIC covers medically necessary state healthcare in the EEA but does not cover repatriation, private treatment or rescue, so it complements rather than replaces a travel policy.

Providers offering cover for declarable lung conditions

Several UK specialists are built around accepting declarable medical conditions rather than turning them away. Staysure, a trading name of TICORP Limited (FCA FRN 663617, administered by Howserv Limited), covers more than 1,300 medical conditions, applies no upper age limit, and provides unlimited emergency medical cover with cancellation up to 15,000 pounds on its Comprehensive and Signature policies. Avanti Travel Insurance, also a trading name of TICORP Limited (administered by Howserv Limited, FCA FRN 599282), likewise supports more than 1,300 pre-existing conditions, with cancellation up to 7,500 pounds and unlimited medical expenses on its Deluxe policies. AllClear, arranged by IES Limited (FCA FRN 824283) with AllClear Insurance Services Limited (firm reference 311244) as UK administrator, screens COPD directly through the questions described above and offers the Gold, Gold Plus and Platinum tiers.

Naming these providers is not a ranking. The point is that travellers with COPD do not need to rely on a generic policy that may exclude their condition. A specialist that screens the lung condition explicitly is more likely to produce a quote that actually responds to a respiratory claim, and comparing the screened quote across more than one specialist is the practical way to test both price and the medical limit on offer.

Common pitfalls

The most damaging error is buying on price alone from a non-specialist that never asked about lung conditions, then assuming COPD is covered. If the screening did not capture it, a flare-up claim can be refused. A second pitfall is declaring the diagnosis but understating severity, for example omitting a recent hospital admission or a new oxygen prescription, which can have the same effect as not declaring at all. A third is treating a GHIC as a substitute for insurance, when it does not fund repatriation or private care. A fourth is letting a policy lapse over a long stay so that part of the trip is uncovered, against the FCDO advice to cover the full length of the trip. Finally, travellers sometimes forget to re-screen after a change in medication between purchase and departure, which can affect whether the stated cover still applies.

If you cannot find suitable cover

If you find it difficult to get cover because of a pre-existing condition, the Money and Pensions Service operates a travel insurance directory of specialist providers via its MoneyHelper service. Visit the MoneyHelper travel insurance directory or call the Money Helper Customer Contact Centre on 0800 138 7777 (Monday to Friday, 8am to 6pm).

Kael Tripton is an independent publisher. Not a broker. Not authorised by the FCA. ICO registered ZC135439. This article is editorial, not financial advice. Verify current rates and terms directly with providers.

Sources

Advertisement

Editorial Disclaimer

The content on Kaeltripton.com is for informational and educational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Kaeltripton.com is not authorised or regulated by the Financial Conduct Authority (FCA) and is not a financial adviser, mortgage broker, insurance intermediary or investment firm. Nothing on this site should be construed as a personal recommendation. Rates, figures and product details are indicative only, subject to change without notice, and should always be verified directly with the relevant provider, HMRC, the FCA register, the Bank of England, Ofgem or other appropriate authority before any financial decision is made. Past performance is not a reliable indicator of future results. If you require regulated financial advice, please consult a qualified adviser authorised by the FCA.

CT
Chandraketu Tripathi
Finance Editor · Kaeltripton.com
Chandraketu (CK) Tripathi, founder and lead editor of Kael Tripton. 22 years in finance and marketing across 23 markets. Writes on UK personal finance, tax, mortgages, insurance, energy, and investing. Sources: HMRC, FCA, Ofgem, BoE, ONS.

Stay ahead of your money

Free UK finance guides, rate changes and money-saving tips — straight to your inbox. No spam, unsubscribe anytime.

Read More

Get Kael Tripton in your Google feed

⭐ Add as Preferred Source on Google